Biopharmaceutical company recognized for innovation in the development of immune-modulatory therapeutic cancer vaccines –NEW YORK, March 18, ...
It's getting tougher to have a successful biotech initial public offering in ... withdrawals could be a warning sign that investors are shifting focus to profitability, amid macro concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results